Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis

We present a case report of a patient with cryoglobulin-vasculitis caused by multiple myeloma in Durie/Salmon stage I refractory to conventional therapy modalities treated with high-dose chemotherapy followed by autologous blood stem cell transplantation. While clinical symptoms of vasculitis disapp...

Full description

Saved in:
Bibliographic Details
Main Authors: Hillengaß, Jens (Author) , Ho, Anthony Dick (Author) , Goldschmidt, Hartmut (Author) , Waldherr, Rüdiger (Author) , Möhler, Thomas (Author)
Format: Article (Journal)
Language:English
Published: 11 October 2008
In: International journal of hematology
Year: 2008, Volume: 88, Issue: 4, Pages: 454-456
ISSN:1865-3774
DOI:10.1007/s12185-008-0177-1
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s12185-008-0177-1
Get full text
Author Notes:J. Hillengass, A. D. Ho, H. Goldschmidt, R. Waldherr, T. M. Moehler
Description
Summary:We present a case report of a patient with cryoglobulin-vasculitis caused by multiple myeloma in Durie/Salmon stage I refractory to conventional therapy modalities treated with high-dose chemotherapy followed by autologous blood stem cell transplantation. While clinical symptoms of vasculitis disappeared, elevated cryoglobulin levels persisted. Therefore we conclude that the relief of symptoms was caused by an immunomodulation induced by the autologous stem cell transplantation.
Item Description:Gesehen am 14.01.2022
Physical Description:Online Resource
ISSN:1865-3774
DOI:10.1007/s12185-008-0177-1